Objective: 1) To assess the association between tongue position, classified by both Mallampati (MP) and Friedman Tongue Position (FTP) scales, and severity of sleep apnea (OSA) as determined by the apnea-hypopnea index (AHI). 2) To determine which of these assessment methods is most closely correlated with OSA severity.
Objective: 1) To assess the association between tongue position, classified by both Mallampati (MP) and Friedman Tongue Position (FTP) scales, and severity of sleep apnea (OSA) as determined by the apnea-hypopnea index (AHI). 2) To determine which of these assessment methods is most closely correlated with OSA severity.
Method: PubMed, MEDLINE, and Cochrane Trial Registry through December 2011 were searched, combined with review of relevant article bibliographies. All studies were assessed by 3 reviewers. Systematic review and random-effects meta-analysis of studies assessing the association of tongue position and OSA severity were performed. Outcomes are reported as correlations.
Results: Ten studies met inclusion criteria and had data suitable for pooling (2515 patients). Overall, increasing tongue position (categorical variable) was significantly associated with increasing OSA severity (continuous variable of AHI) with a correlation of .351 (95% CI .094, .564; P = .008). Sensitivity analysis revealed correlations of .184 (95%CI .052, .310; P = .006) and .388 (95% CI .049, .646; P = .026) for MP and FTP, respectively. Analysis of publication bias revealed a nonsignificant Egger's regression intercept; however, 4 imputed values to the right of the mean were found using Duval and Tweedie's trim and fill method. Adding these values yielded an overall correlation of .498 (95% CI .474, .521).
Conclusion:
Both the MP and FTP assessment techniques are significantly correlated with OSA severity. Publication bias does not affect or skew our results. The strength of the correlation between AHI and tongue position is greater for FTP than for MP, though the 95% confidence intervals for their respective correlation coefficients overlap.
Sleep Medicine Friedman Staging for Sleep Surgery: Meta-analysis
Michael Friedman, MD (presenter); Craig S. Hamilton, MD; Christian G. Samuelson, MD Objective: 1) Review the available literature reporting on the success of single and multi-level sleep surgery in relation to Friedman Anatomical Staging (FAS). 2) Combine statistical outcomes of multiple studies (where appropriate) to determine surgical success rates (defined by postoperative apnea-hypopnea index [AHI] <20 and 50% reduction) for each clinical stage.
Method: PubMed, MEDLINE, and Cochrane Trial Registry (through 12/2011) were searched, combined with manual review of relevant article bibliographies. All studies were assessed by 3 reviewers. Systematic review and random-effects meta-analysis of studies assessing the success of sleep surgery in relation to FAS were performed. Outcomes are reported as proportional success rates.
Results: Six studies met inclusion criteria and had data suitable for pooling (521 patients). Success rate (SR) for single-level palatal surgery with FAS-1 was .806 (.630, .910; P = .002). Multi-level surgical data for FAS-1 yielded SR .706 (.458, .872; P = .1). Single-level surgery for FAS-2 yielded SR .379 (.224, .564; P = .197 ). Multi-level surgical data for FAS-2 yields SR .647 (.527, .751; P = .017). Single-level surgery for FAS-3 yields SR .081 (.037, .169; P < .001). Multi-level surgery for FAS-3 yields SR .412 (.254, .591; P = .334). Analysis of publication bias yielded non-significant Egger's regression intercepts for studies reporting FAS-2/3 success. Too few studies reported FAS-1 success to allow statistical analysis of publication bias.
Conclusion: These findings demonstrate the utility of FAS in predicting the success of OSA surgery. Findings further reinforce the value of OSA surgery in patients with FAS-1 regardless of disease severity. In addition, they add to the evidence that multi-level surgery is often necessary to treat patients with more advanced staging.
Sleep Medicine Mandibular Advancement for Obstructive Sleep Apnea: Relating Outcomes to Anatomy
Michael Friedman, MD (presenter); Craig S. Hamilton, MD; Christian G. Samuelson, MD Objective: Previous studies assessing the correlation between airway anatomic factors and success with oral appliance (OA) therapy in the treatment of obstructive sleep apnea (OSA) have failed to reach consensus. We aim to assess the role of regional upper airway obstruction measured by acoustic pharyngometry as a determinant of OA success.
Method:
In this outpatient case-series, data from OSA patients (100% CPAP-failures) fitted with a custom OA between 07/2011-01/2012 were reviewed. Regional maximal upper airway collapse was determined on acoustic pharyngometry and classified as retropalatal (RP), retroglossal (RG), or retroepiglottic (RE). Apnea-hypopnea index (AHI) improvement on titrationpolysomnography was assessed against regional collapse.
Results: Seventy-five patients (74.7% male, age 49.0 ± 13.6, BMI 29.4 ± 5.2, mean AHI 30.6 ± 20.0) were assessed and their data grouped on the basis of region of maximal collapse on pharyngometry at respiratory residual volume (RP = 29, RG = 28, RE = 18). Overall AHI reduction at OA-titration was -20.2 (95% CI -23.6, -16.8; P < .001) with no significant difference in AHI reduction between groups. There was no significant difference in the rate of response to treatment when defined as >50% AHI reduction plus AHI <20 (RP = 69%, RG = 75%, RE = 83%; P = .545), or rate of cure defined as AHI <5 (RP = 52%, RG = 43%, RE = 72%; P = .146). Correlation
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of minimum cross-sectional-area and response trended toward significance (r = .202; -.026, .410; P < .1).
Conclusion:
Success with oral appliance therapy is not predicted by identification of the region of maximal upper airway collapse as measured by acoustic pharyngometry. OA therapy achieves reasonable objective response and cure rates in patients with primary retropalatal, retroglossal, or retroepiglottic obstruction at the time of initial titration-polysomnography.
Sleep Medicine OSA Diagnosis by Peripheral Arterial Tonometry
Michael Friedman, MD (presenter); Christian G. Samuelson, MD; Craig S. Hamilton, MD Objective: To assess the correlation between respiratory sleep indices as measured by portable sleep testing using peripheral arterial tonometry (PAT) and respiratory sleep indices as measured by formal polysomnography (PSG). Thereby assess the validity of PAT devices as diagnostic tools for obstructive sleep apnea in the adult population.
Method: PubMed, MEDLINE, Cochrane Trial Registry (through 12/2011), and relevant article bibliographies were searched. Articles were assessed by 3 reviewers. Systematic review and meta-analysis of studies assessing correlation of respiratory sleep indices between PAT devices and PSG in adults (>18 years) was conducted. Included studies provided an r value for correlation.
Results: Eleven studies met inclusion criteria and had data suitable for pooling (775 patients). Of these, 10 studies were "blinded" in that PAT and PSG were conducted simultaneously in either the home or laboratory setting. One study contained 2 trial phases for the same patient group (n = 21), 1 laboratory and 1 home-based, which were analyzed separately. Overall correlation of respiratory sleep indices was high (r = .867, .836-.892, P < .001). Studies comparing respiratory disturbance index (RDI) had a combined r = .854 (.823-.880, P < .001), and those comparing apnea-hypopnea index (AHI) had a combined r = .890 (.833-.929, P < .001). Analysis of publication bias revealed a nonsignificant Egger's regression intercept.
Conclusion: Respiratory indices calculated using PAT-based portable devices correlate well with those calculated from the scoring of formal PSG. The strength of this correlation is supported by the "blinded" nature of the majority of the included studies. This technology represents a viable alternative to PSG for confirmation of clinically suspected sleep apnea.
Sleep Medicine Reflux Disease and Proton Pump inhibitor Therapy: impact upon Sleep Disturbance
Elliot Regenbogen, MD (presenter); Alex Helkin; Rachel Georgopoulos; Tajender Vasu, MD; A. Laurie W. Shroyer, MD Objective: To perform a systematic literature review that evaluates the impact of proton pump inhibitor treatment of gastroesophageal reflux disease upon sleep disturbance-related outcomes.
Method: PubMed, Web of Science, and Cochrane databases were searched from 1989 to present, identifying all radomized placebo-controlled clinical trials where both proton pump inhibitor use and outcome measures of sleep disturbance were reported for esophageal refludisease patients. Using preestablished systematic review protocol 4 co-authors independently reviewed all articles.
Results:
The original search idetified 20 articles; 9 were not directly relevant, and 3 were not placebo controlled. Sample sizes varied from 15 to 642; mean age was 47.4 ± 4.56; mean body mass index was 29.4 ± 2.90; the proportion of women varied widely across studies. Esopmeprazole was studied most frequently. Over 50% of publications permitted rescue antacids. Two studies reported polysomnography outcomes, without statistically significant improvement. All studies reported nonpolysomnography outcomes; 7 identified statistically significant improvements demonstrating drug treatment superiority over placebo.
Conclusion:
The existing evidence supports the use of proton pump inhibitor as a treatment for esophageal reflux disease to improve quality of life sleep disturbance-related outcomes. While variability in treatments and outcomes prevented direct comparisons, this conclusion appears robust for 7 of 8 studies, including the highest 3 quality studies.
Sleep Medicine Radiofrequency Volume Reduction of Tongue Base: A 12-Year Experience Yi H. Kao, MD (presenter)
Objective: 1) To report on the evolution and success rate of radiofrequency volume reduction of the tongue base over a 12-year period. 2) Introduce a novel method for deploying the RFVR probes to the tongue base without pulling the tongue forward. 3) Show reduced complication rates by avoiding nerves and vessels. 4) Show increased success rate with increased number of lesions per treatment session. 5) Demonstrate the possibility of treating the genioglossus and geniohyoid muscles to shorten these muscles and retract the tongue anteriorly.
Method:
In an IRB-approved prospective study at a community hospital, over 400 patients with obstructive sleep apnea over a 12 year period were selected for RFVR of the tongue base when there is evidence of hypopharyngeal involvement. Treatment evolved from single pronged to a double pronged probe with the rapid lesion mode and from to 2 lesions to 14 lesions. RFVR is usually performed in conjunction as part of multilevel treatment. Polysomnography prior to and 3 months after treatment were analyzed. Complications were recorded. Success is defined as RDI less than 20 and a greater than 50% reduction from preoperative levels.
